HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Claudio Meneses Selected Research

Salivary Proteins and Peptides

10/2022Development of Inapparent Dengue Associated With Increased Antibody Levels to Aedes aegypti Salivary Proteins: A Longitudinal Dengue Cohort in Cambodia.
10/2020Engineering a vector-based pan-Leishmania vaccine for humans: proof of principle.
1/2020Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trial.
1/2019DNA plasmid coding for Phlebotomus sergenti salivary protein PsSP9, a member of the SP15 family of proteins, protects against Leishmania tropica.
1/2016Intradermal Immunization of Leishmania donovani Centrin Knock-Out Parasites in Combination with Salivary Protein LJM19 from Sand Fly Vector Induces a Durable Protective Immune Response in Hamsters.
6/2015A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates.
7/2014A Listeria monocytogenes-based vaccine that secretes sand fly salivary protein LJM11 confers long-term protection against vector-transmitted Leishmania major.
3/2014Enhanced protective efficacy of nonpathogenic recombinant leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen.
12/2012Immunity to sand fly salivary protein LJM11 modulates host response to vector-transmitted leishmania conferring ulcer-free protection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Claudio Meneses Research Topics

Disease

11Bites and Stings (Sting)
01/2021 - 12/2012
8Infections
10/2022 - 01/2016
7Leishmaniasis
10/2020 - 01/2012
6Visceral Leishmaniasis (Kala Azar)
01/2021 - 07/2010
4Cutaneous Leishmaniasis
01/2019 - 03/2014
2Atrophy
01/2017 - 12/2015
1Dengue (Dengue Fever)
10/2022
1Cysts
01/2022
1Inflammation (Inflammations)
10/2020
1Erythema
01/2020
1Pain (Aches)
01/2020
1Exanthema (Rash)
01/2020
1Pruritus (Itching)
01/2020
1Vector Borne Diseases
01/2020
1Mosquito-Borne Diseases
01/2020
1Fatty Liver
01/2017
1Ulcer
12/2012

Drug/Important Bio-Agent (IBA)

9Salivary Proteins and PeptidesIBA
10/2022 - 12/2012
8VaccinesIBA
01/2021 - 01/2012
3Proteins (Proteins, Gene)FDA Link
10/2022 - 06/2015
2AntigensIBA
01/2022 - 03/2014
2Hydrocortisone (Cortisol)FDA LinkGeneric
08/2021 - 12/2015
2Leishmaniasis VaccinesIBA
01/2021 - 10/2020
2Heme Oxygenase-1IBA
10/2020 - 01/2018
2CytokinesIBA
04/2014 - 02/2013
1EnzymesIBA
10/2022
1AntibodiesIBA
10/2022
1ImmunosorbentsIBA
10/2022
1Neutralizing AntibodiesIBA
10/2022
1Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
01/2022
1RNA (Ribonucleic Acid)IBA
08/2021
1Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
01/2021
1Interleukin-10 (Interleukin 10)IBA
01/2021
1IsoenzymesIBA
10/2020
1Heme (Haem)IBA
10/2020
1IronIBA
10/2020
1miltefosine (Impavido)IBA
12/2019
1N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA
12/2019
1Interleukin-5 (Interleukin 5)IBA
01/2019
1Transcription Factors (Transcription Factor)IBA
12/2018
1InflammasomesIBA
01/2018
1UbiquitinIBA
01/2017
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2017
1Alkaline PhosphataseIBA
01/2017
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2017
1Alanine Transaminase (SGPT)IBA
01/2017
1Messenger RNA (mRNA)IBA
12/2015
1ChemokinesIBA
04/2014
1Recombinant ProteinsIBA
12/2012
1Pharmaceutical PreparationsIBA
07/2010
1Attenuated VaccinesIBA
07/2010

Therapy/Procedure

1Intradermal Injections
01/2021
1Subcutaneous Injections
01/2020